Sign In
28 Apr 2011 07:00
๏ปฟ
ย
Immunodiagnostic Systems Holdings PLC ("IDS" or "the Company")
ย
28 April 2011
ย
VOTING RIGHTS AND CAPITAL
ย
IDS, a leading producer of diagnostic testing kits, makes the following announcement in accordance with the Disclosure and Transparency Rules.
ย
The Company'sย issuedย shareย capital consists ofย 28,236,915 ordinary shares with a nominal value ofย 2p each ('Ordinary Shares').ย The Companyย does not holdย anyย Ordinaryย Shares in Treasury.
ย
Therefore, the total number of votingย rights inย the Companyย isย 28,236,915.
ย
The figure ofย 28,236,915 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in,ย the Companyย under the FSA's Disclosure andย Transparencyย Rules.
ย
For further information:
ย
Immunodiagnostic Systems Holdings plc | Tel: 0191 519 0660 |
Ian Cookson, Chief Executive Officer | |
Paul Hailes, Finance Director | |
Brewin Dolphin | Tel: 0845 213 4730 |
Matt Davis | |
Sean Wyndham-Quin | |
Walbrook PR Ltd | Tel: 020 7933 8787 |
Paul McManus / Fiona Henson | Mob: 07980 541 893 / 07886 335 992 |
paul.mcmanus@walbrookpr.com | |
fiona.henson@walbrookpr.com |
ย
Follow the stocks
